Your browser doesn't support javascript.
loading
Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing.
Ruiz-Heredia, Yanira; Sánchez-Vega, Beatriz; Onecha, Esther; Barrio, Santiago; Alonso, Rafael; Martínez-Ávila, Jose Carlos; Cuenca, Isabel; Agirre, Xabier; Braggio, Esteban; Hernández, Miguel-T; Martínez, Rafael; Rosiñol, Laura; Gutierrez, Norma; Martin-Ramos, Marisa; Ocio, Enrique M; Echeveste, María-Asunción; de Oteyza, Jaime Pérez; Oriol, Albert; Bargay, Joan; Gironella, Mercedes; Ayala, Rosa; Bladé, Joan; Mateos, María-Victoria; Kortum, Klaus M; Stewart, Keith; García-Sanz, Ramón; Miguel, Jesús San; Lahuerta, Juan José; Martinez-Lopez, Joaquín.
Afiliação
  • Ruiz-Heredia Y; Department of Hematology, Hospital Universitario 12 de Octubre-Hematological Malignancies Clinical Research Unit H120-CNIO, Madrid, Spain.
  • Sánchez-Vega B; Department of Hematology, Hospital Universitario 12 de Octubre-Hematological Malignancies Clinical Research Unit H120-CNIO, Madrid, Spain.
  • Onecha E; Department of Hematology, Hospital Universitario 12 de Octubre-Hematological Malignancies Clinical Research Unit H120-CNIO, Madrid, Spain.
  • Barrio S; Department of Internal Medicine II, University Hospital Würzburg, Germany.
  • Alonso R; Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Martínez-Ávila JC; Clinical Pharmacology Department, La Paz University Hospital, idiPAZ, UAM, Madrid, Spain.
  • Cuenca I; Department of Hematology, Hospital Universitario 12 de Octubre-Hematological Malignancies Clinical Research Unit H120-CNIO, Madrid, Spain.
  • Agirre X; Department of Hematology, Fundación de Investigacion Médica Aplicada (FIMA), Pamplona, Spain.
  • Braggio E; Department of Hematology, Mayo Clinic, Phoenix/Scottsdale, AZ, USA.
  • Hernández MT; Department of Hematology, Hospital Universitario de Canarias, Tenerife, Spain.
  • Martínez R; Department of Hematology, Hospital Clínico Universitario San Carlos, Madrid, Spain.
  • Rosiñol L; Department of Hematology, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Spain.
  • Gutierrez N; Department of Hematology, Hospital Universitario de Salamanca-Centro Investigación del Cáncer and Hospital Universitario-IBSAL, Salamanca, Spain.
  • Martin-Ramos M; Department of Hematology, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Spain.
  • Ocio EM; Department of Hematology, Hospital Universitario de Salamanca-Centro Investigación del Cáncer and Hospital Universitario-IBSAL, Salamanca, Spain.
  • Echeveste MA; Department of Hematology, Hospital Universitario Donostia, San Sebastián, Spain.
  • de Oteyza JP; Department of Hematology, Hospital Madrid Norte Sanchinarro, Madrid, Spain.
  • Oriol A; Department of Hematology, Hospital Universitario de Salamanca-Centro Investigación del Cáncer and Hospital Universitario-IBSAL, Salamanca, Spain.
  • Bargay J; Department of Hematology, Hospital Sont Llatzer, Palma de Mallorca, Spain.
  • Gironella M; Department of Hematology, Hospital Universitario Vall de Hebrón de Barcelona, Spain.
  • Ayala R; Department of Hematology, Hospital Universitario 12 de Octubre-Hematological Malignancies Clinical Research Unit H120-CNIO, Madrid, Spain.
  • Bladé J; Department of Hematology, Hospital Clinic i Provincial, Institut d'Investigasions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Mateos MV; Department of Hematology, Hospital Universitario de Salamanca-Centro Investigación del Cáncer and Hospital Universitario-IBSAL, Salamanca, Spain.
  • Kortum KM; Department of Internal Medicine II, University Hospital Würzburg, Germany.
  • Stewart K; Department of Hematology, Mayo Clinic, Phoenix/Scottsdale, AZ, USA.
  • García-Sanz R; Department of Hematology, Hospital Universitario de Salamanca-Centro Investigación del Cáncer and Hospital Universitario-IBSAL, Salamanca, Spain.
  • Miguel JS; Department of Hematology, Fundación de Investigacion Médica Aplicada (FIMA), Pamplona, Spain.
  • Lahuerta JJ; Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Martinez-Lopez J; Department of Hematology, Hospital Universitario 12 de Octubre-Hematological Malignancies Clinical Research Unit H120-CNIO, Madrid, Spain jmarti01@med.ucm.es.
Haematologica ; 103(11): e544-e548, 2018 11.
Article em En | MEDLINE | ID: mdl-29954938
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Bases de Dados de Ácidos Nucleicos / Mieloma Múltiplo / Proteínas de Neoplasias Tipo de estudo: Clinical_trials / Diagnostic_studies / Screening_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Haematologica Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Bases de Dados de Ácidos Nucleicos / Mieloma Múltiplo / Proteínas de Neoplasias Tipo de estudo: Clinical_trials / Diagnostic_studies / Screening_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Haematologica Ano de publicação: 2018 Tipo de documento: Article